APA
Franchi F., Rollini F., Kairouz V., Rivas Rios J., Rivas A., Agarwal M., Briceno M., Wali M., Nawaz A., Silva G., Shaikh Z., Maaliki N., Been L., Piraino J., Pineda A. M., Suryadevara S., Soffer D., Zenni M. M., Jennings L. K., Bass T. A. & Angiolillo D. J. (2019). Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study. : JACC. Basic to translational science.
Chicago
Franchi Francesco, Rollini Fabiana, Kairouz Victor, Rivas Rios Jose, Rivas Andrea, Agarwal Malhar, Briceno Maryuri, Wali Mustafa, Nawaz Ahmed, Silva Gabriel, Shaikh Zubair, Maaliki Naji, Been Latonya, Piraino Jason, Pineda Andres M, Suryadevara Siva, Soffer Daniel, Zenni Martin M, Jennings Lisa K, Bass Theodore A and Angiolillo Dominick J. 2019. Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study. : JACC. Basic to translational science.
Harvard
Franchi F., Rollini F., Kairouz V., Rivas Rios J., Rivas A., Agarwal M., Briceno M., Wali M., Nawaz A., Silva G., Shaikh Z., Maaliki N., Been L., Piraino J., Pineda A. M., Suryadevara S., Soffer D., Zenni M. M., Jennings L. K., Bass T. A. and Angiolillo D. J. (2019). Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study. : JACC. Basic to translational science.
MLA
Franchi Francesco, Rollini Fabiana, Kairouz Victor, Rivas Rios Jose, Rivas Andrea, Agarwal Malhar, Briceno Maryuri, Wali Mustafa, Nawaz Ahmed, Silva Gabriel, Shaikh Zubair, Maaliki Naji, Been Latonya, Piraino Jason, Pineda Andres M, Suryadevara Siva, Soffer Daniel, Zenni Martin M, Jennings Lisa K, Bass Theodore A and Angiolillo Dominick J. Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study. : JACC. Basic to translational science. 2019.